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growth of contaminating Lactobacillus found
in fuel ethanol fermentations
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Background: Reduced yields of ethanol due to bacterial contamination in fermentation cultures weaken the
economics of biofuel production. Lactic acid bacteria are considered the most problematic, and surveys of
commercial fuel ethanol facilities have found that species of Lactobacillus are predominant. Bacteriophage lytic
enzymes are peptidoglycan hydrolases that can degrade the Gram positive cell wall when exposed externally and
provide a novel source of antimicrobials that are highly refractory to resistance development.
Results: The streptococcal phage LambdaSa2 (λSa2) endolysin demonstrated strong lytic activity towards 17 of 22
strains of lactobacilli, staphylococci or streptococci and maintained an optimal specific activity at pH 5.5 and in
the presence of ≤ 5% ethanol (fermentation conditions) toward L. fermentum. Lactobacillus bacteriophage
endolysins LysA, LysA2 and LysgaY showed exolytic activity towards 60% of the lactobacilli tested including four
L. fermentum isolates from fuel ethanol fermentations. In turbidity reduction assays LysA was able to reduce
optical density >75% for 50% of the sensitive strains and >50% for the remaining strains. LysA2 and LysgaY were
only able to decrease cellular turbidity by <50%. Optimal specific activities were achieved for LysA, LysA2, and
LysgaY at pH 5.5. The presence of ethanol (≤5%) did not reduce the lytic activity. Lysins were able to reduce
both L. fermentum (BR0315-1) (λSa2 endolysin) and L. reuteri (B-14171) (LysA) contaminants in mock fermentations
of corn fiber hydrolysates.
Conclusion: Bacteriophage lytic enzymes are strong candidates for application as antimicrobials to control lactic
acid bacterial contamination in fuel ethanol fermentations.
Keywords: Bacteriophage, Lysin, endolysin, Peptidoglycan, Ethanol, Fermentation, Contamination, Lactic acid
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The fuel ethanol industry has experienced rapid growth
in recent years, with 10.6 billion gallons of ethanol pro-
duced in 2009 and future need estimated to be 60 billion
gallons by 2030 in the United States alone [1]. Currently,
the majority of ethanol is produced from renewable
carbohydrate-rich feedstock such as cornstarch or sugar-
cane, but to achieve higher demands in the future, ligno-
cellulosic biomass will need to be utilized. Weakening
the economics of biofuel production are ethanol losses* Correspondence: david.donovan@ars.usda.gov
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reproduction in any medium, provided the ordue to bacterial contamination of fermentation cultures.
Contributing to this concern is the fact that it is not feas-
ible to produce fuel ethanol under aseptic conditions,
therefore chronic and acute contaminations are com-
monplace [2-5]. A variety of Gram positive and Gram
negative bacteria have been isolated from commercial
fuel ethanol production facilities [3,5,6]. However, it is
generally believed that lactic acid bacteria (LAB) are the
most detrimental, with Lactobacillus species predominat-
ing [5-7]. Lactobacilli thrive in the industrial fermenta-
tion environments because they are well adapted for
survival under the high ethanol, low pH and low oxygen
conditions. A major culprit, L. fermentum, has been
shown to reduce ethanol production in Saccharomyces
cerevisiae fermentation cultures by as much as 27% [6,8].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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prophylactic antibiotic treatments and/or costly produc-
tion shutdowns for extensive cleaning and disinfecting
[5,9,10]. Despite current control measures and practices,
long-term suppression of microbial contamination is still
a major challenge in ethanol production.
There are numerous theories to account for the effect
contaminants have on yeast during ethanol production.
Chronic LAB contaminants are believed to compete for
sugars available for conversion to ethanol as well as es-
sential micronutrients required for optimal yeast growth.
Acute contaminations often lead to the accumulation of
major inhibitory end-products such as acetic and lactic
acid that inhibit yeast growth and, if left untreated, cause
“stuck” fermentations [5,11,12]. Besides lowering the pH
of the fermentation below the optimal S. cerevisiae pH
range for the conversion of sugars to ethanol, the acid’s
true inhibitory effect has been postulated to be from the
undissociated form of the acid that is capable of diffusing
through the yeast cell membrane where it dissociates,
acidifying the cytoplasm [13]. Other compounds pro-
duced by LAB are known to contribute to the inhibition
of ethanol production such as diacetyl [14], fatty acids
[15] and the broad spectrum antibiotic reuterin [13,16].
Several techniques are currently being employed in an
attempt to control microbial contaminants. In the United
States, bacterial contaminants are commonly controlled
with the commercially available antibiotics virginiamycin,
penicillin, and erythromycin [5,9,10]. Treatment for con-
tamination is often prophylactic, necessitating the
addition of antibiotics to each fermentation cycle. How-
ever, decreased susceptibility to virginiamycin has already
been observed in Lactobacillus species isolated from
dry-grind ethanol plants that use virginiamycin [17]
and the emergence of isolates with multidrug resist-
ance to both virginiamycin and penicillin have also
been reported [9,17]. In addition, concerns over the
potential for antibiotic residues to persist in the distil-
lers grains co-products may further limit their use dur-
ing ethanol production [18]. A ‘no-antibiotic’ approach
has obvious advantages, but acceptable alternatives are
currently lacking.
Bacteriophage (phage) endolysins are lytic enzymes
produced by bacterial viruses. During phage infection
of bacteria, lysins are produced near the end of the
phage replication cycle to degrade peptidoglycan (PG)
(a major structural component of the bacterial cell
wall) that leads to cell lysis (‘lysis from within’) and
phage progeny release (reviewed in [19]). Scientists
have found that externally lysin-treated bacteria still
lyse (exolysis or ‘lysis from without’), which has been
exploited to control pathogenic and problematic bac-
teria [20-23]; for review see [24]. Currently, lysins are
only exolytic for Gram positive bacteria that lack anouter membrane, which prevents access of the lysin to
the PG of Gram negative bacteria. Lysins exert their
lethal effects by forming holes in the PG. This degrad-
ation of the cells wall, results in the extrusion of the
cytoplasmic membrane due to the approximately 30 or
40 atm intracellular pressure resulting in osmolysis
[24]. PG is unique to bacteria and has a complex
structure [25] with a sugar backbone of alternating units
of N-acetyl glucosamine and N-acetyl muramic acid.
Typically, these sugar polymers are cross-linked by
species-specific oligopeptide attachments at the N-acetyl
muramic acid residues (Figure 1a). Phage lysins have
evolved a modular design to deal with PG complexity,
generally consisting of both lytic domains and cell wall
binding (CWB) domains (Figure 1b). Catalytically, a sin-
gle lysin molecule should be sufficient to cleave an ad-
equate number of bonds to lyse a bacterial wall [26].
There are numerous candidate lactobacilli lysin genes
available in both phage genomes and prophage genomes
within public data sets. We have attempted to isolate
and screen seven phage lysins for their ability to kill six
Lactobacillus strains isolated from fuel ethanol fermen-
tations and sixteen other Gram positive strains. Of these
lysins, three lactobacilli lysins: LysA [27], LysA2 [28] and
LysgaY [29], and a streptococcal phage LambdaSa2
(λSa2) lysin [30,31], were successfully expressed, purified
and examined in this study. We demonstrate that LysA
and λSa2 endolysin are highly exolytic against a variety
of lactobacilli including the notorious L. fermentum con-
taminant, under laboratory conditions that mimic etha-
nol fermentation environments. These results suggest
that lysins have the potential to control unwanted lacto-
bacilli contaminations in fermentation systems.
Results
Lysin purification
We were unable to purify three of seven cloned putative
lytic proteins ABJ8901 [GenBank:ABJ8901], BAG8101
[GenBank: BAG8101] and Lyb5 from phiPBY5 [32], due
to complications during IPTG induction of E. coli BL21
(DE3) transformed cells. [After induction, the E. coli cul-
ture unexpectedly autolysed which led to culture failure
(data not shown).] Induction and purification of putative
lytic proteins λSa2 endolysin, LysgaY, LysA2, and LysA
occurred without complication. SDS-PAGE analysis of
the nickel chromatography purified proteins produced
prominent bands for λSa2 endolysin, LysgaY, LysA2 and
LysA that migrated to positions in the SDS PAGE con-
sistent with their predicted molecular masses of 51.9 kD,
33.9 kD, 37.4 kD, and 36.4 kD, respectively (Figure 2a).
Lysin exolytic activity and bacteria susceptibility spectrum
Zymogram analysis was performed with whole cells of
L. reuteri 14171 or L. amylovorus 4540 co-polymerized
Figure 1 Schematic representation of PG, putative lysin catalytic sites and domain structures of bacteriophage lysins. a) Fragment of
the repeat structure of Lactobacillus fermentum PG with a D-Asp interpeptide bridge with known enzymatic cut sites: (1a) λSa2 endolysin; (3a)
λSa2 endolysin; (3b) LysA2, and predicted lysin catalytic sites: (1b*) Lyb5, LysgaY, and LysA; (2*) ABJ8901 [GenBank: ABJ63875] and BAG8101
[GenBank:BAG27815]. * Predicted catalytic sites are based on amino acid homologies to other biochemically characterized enzymes. b) Lysin
architecture consisting of an enzymatically active domain(s) (square box) and cell wall binding domain(s) (hexagon box) drawn nearly to scale
predicted using the NCBI Conserved Domain Database. A His6-tag (dot box; not to scale) was fused on the C-terminal for metal ion affinity
chromatography purification.
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translucent or dark bands, indicating lysis of the embed-
ded cells, were observed in each lane at approx. 52 kD,
38 kD, 35 kD, and 37 kD, in agreement with the pre-
dicted MW of λSa2 endolysin, LysgaY, LysA2, and LysA,



















Figure 2 SDS-PAGE and exolytic activity analyses of Immobilized Met
PAGE with high intensity bands correspond to predicted molecular weight
and LysA (36.4 kD). b) Zymogram analysis with whole cells substrate (i) Lac
4540, co-polymerized within the polyacrylamide gel. Lysin exolytic activity
point of protein localization, which corresponds with predicted molecular wPurified lysins were tested in turbidity reduction assays
for their ability to lyse log phase cultures of several bac-
terial species (Table 1). The λSa2 endolysin had strong
lytic activity towards 17 of 22 lactobacilli, staphylococci
or streptococci, and weaker activity towards another



















al Affinity Chromatography purified recombinant lysins. a) SDS-
s for lysins λSa2 endolysin (51.9 kD), LysgaY (33.9 kD), LysA2 (37.4 kD),
tobacillus reuteri isolate 14171 and (ii) Lactobacillus amylovorus isolate
resulted in visible clearing (dark bands) of the cell substrate at the
eights.
Table 1 Activity of LysA, LysA2, LysgaY and λSa2 endolysin against lactic acid bacteria as determined by turbidity
(OD600nm) reduction analysis
Activitya
Strain LysA LysA2 LysgaY λSa2 Strain Source
Gram positive
Lactobacillus amylovorus B-4540 - ++ ++ ++ NRRLb
Lactobacillus brevis 0605-48 ++ ++ ++ ++ this studyc
Lactobacillus delbrueckii subsp delbrueckii B-763 - - + + NRRL
Lactobacillus fermentum BRO315-1 ++ + + ++ this study
Lactobacillus fermentum BRO315-25 ++ + + +++ this study
Lactobacillus fermentum 0605-B44 +++ + + +++ this study
Lactobacillus fermentum 0713-3 +++ + + +++ this study
Lactobacillus gasseri B-4240 +++ + + +++ NRRL
Lactobacillus hilgardii B-1843 - - - - NRRL
Lactobacillus malefermentans B-1861 - - - ++ NRRL
Lactobacillus paracasei BRO315-44 - - - - this study
Lactobacillus reuteri B-14171 ++ + ++ + NRRL
Staphylococcus aureus Newman + - + +++ Jean C. Leed
Staphylococcus epidermidis + - ++ +++ USDA
Staphylococcus hyicus - - - + USDA
Staphylococcus warneri + - + +++ USDA
Staphylococcus xylocus ++ - ++ +++ USDA
Streptococcus agalactiae ++ - ++ +++ David Pritcharde
Streptococcus dysgalactiae ++ - ++ +++ USDA
Streptococcus pyogenes + - + +++ Dan Nelsonf
Streptococcus suis 531-668 +++ - +++ +++ Dan Nelsonf
Weisella viridescens B-1951 - - + +++ NRRL
Yeast
Saccharomyces cerevisiae Y-2034 - - - - NRRL
Gram negative
Escherichia coli DH5α - - - - Invitrogen
a As measured by OD600nm, decrease of whole cell suspensions (initial OD600nm = ~1) treated with lysin (10μM) for 30 min. “+++” between 100% and 75%
decrease, “++” between 74% and 50% decrease, “+” less than 49% decrease, “−“no decrease, with respect to no lysin control.
b ARS Culture Collection, Peoria, IL (also known as the NRRL Collection).
c Isolated from fermentors at a commercial dry-grind ethanol facility as described previously [6]. L. fermentum BR0315-1, BR0315-25, and 0713–3 were planktonic
isolates, and their MICs for virginiamycin are 16 μg/ml, ≤2 μg/ml, and ≤2 μg/ml, respectively. L. fermentum 0605-B44 was a biofilm isolate from coupon scrapings
of a Centers for Disease Control biofilm reactor inoculated with a mash sample from the fermentor.
d Channing Lab, Womens and Brigham Hospital, Boston, MA.
e Dept. Biochemistry, Medical School, Univ. Alabama, Birmingham.
f Department of Veterinary Medicine, UMD, College Park MD.
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cluding all four L. fermentum isolates, and L. gasseri, L.
brevis and L. reuteri. LysA was able to reduce cell popula-
tions >75% for 50% of the sensitive strains and >50% for
the remaining strains tested. However, LysA2 and LysgaY
were only able to decrease cellular turbidity by <50%. Inter-
estingly, LysA and LysgaY had exolytic activity towards
100% of the streptococci and 80% of the staphylococci
tested, whereas LysA2 did not show any exolytic activity
towards the non LAB species tested. None of the lysinstested had exolytic activity towards the Gram negative E.
coli DH5α or the yeast strain of S. cerevisiae.
Sensitivity of exolytic activity to pH and ethanol
The functional properties for lysins LysA, LysA2, LysgaY
and λSa2 endolysin were tested under a range of pH and
ethanol concentrations with turbidity reduction analysis
using live cells of L. fermentum isolates 0605-B44 and
BR0315-1, and L. brevis isolate 0605–48, as substrate.
Optimal specific activity was achieved for LysA, LysA2,
Figure 3 Turbidity reduction analysis of LysA, LysA2, LysgaY and λSa2 endolysin against multiple lactobacilli in a range of pH and
ethanol concentrations. a) Effect of pH on turbidity reduction specific activities (OD600nm/min/μM; as described by [49]). b) Effect of ethanol on
lysin activity (normalized to specific activity achieved at pH 5.5 in panel a). Live cells of L. fermentum isolate 0605-B44 (blue), L. fermentum isolate
BR0315-1 (green), and L. brevis isolate 0605–48 (red) were used as substrate. Data represent the average of three experiments (n=3) ± SEM.
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strated strong exolytic activity between pH 5.5 and pH
6.5 (Figure 3a). For these three lysins, the presence of
ethanol (≤5%) in the turbidity reduction assay did not
reduce the maximum activity achieved (Figure 3b). How-
ever, LysgaY activity improved approximately 3-fold
when L. brevis was used as substrate in the presence of
3% ethanol and nearly 5 fold at 5% ethanol. The strepto-
cocci phage λSa2 endolysin produced its optimal specific
activity at a slightly higher pH of 6.5 and also was not
affected by the presence of ethanol (≤5%) for both L. fer-
mentum substrates. However, activity with L. brevis sub-
strate in ≤1% ethanol completely abolished exolytic
activity.
Lysins are exolytic in the fermentation environment
Industrial fermentation substrates have high sugar
concentrations, and, for hydrolysates of lignocellulo-
sic biomass, may also contain lignin degradation pro-
ducts (e.g. phenolic acids, acetic acid, and furfural).
To test whether this environment may inhibit our
lysins, we tested the efficacy of the lysin λSa2 and
LysA to reduce viable L. fermentum (BR0315-1) and
L. reuteri (B-14171) in mock fermentations of corn
fiber hydrolysates. λSa2 endolysin was tested at a
final concentration of 250ng/μl, 75ng/μl, and 25ng/μl
in a fermentation experimentally inoculated with
1x104 CFU/ml L. fermentum. Bacterial loads incultures treated with λSa2 endolysin decreased within
30 min, and by 60 min, reductions in bacterial concen-
tration ranged from ~1.5 log10 (CFU/ml) at 25 ng/μl
λSa2 endolysin to ~2.5 log10 (CFU/ml) at 250ng/μl
λSa2 endolysin (Figure 4a). LysA had diminished exoly-
tic activity compared to λSa2 endolysin, generating a
reduction of only ~0.45 log10 (CFU/ml) in hydrolysates
containing 1x104 CFU/ml (Figure 4a). LysA was also
tested against L. reuteri to demonstrate lysin abilities to
kill other Lactobacillus species (Figure 4c). In hydroly-
sates spiked with 4 log10 (CFU/ml) L. reuteri, LysA was
able to reduce inoculum by ~1.39 log10 (CFU/ml)
(Figure 4c).
Since contaminating bacterial loads in commercial
fermentation cultures may reach 106 to 108 CFU/ml
[3], the λSa2 endolysin (25 ng/μl) was tested against
107 CFU/ml L. fermentum BR0315-1. After 60 min,
λSa2 endolysin reduced bacterial load from 7.0 log10
(CFU/ml) to 5.5 log10 (CFU/ml) (Figure 4b), a similar
level of reduction shown in the mock fermentation con-
taminated with 1x104 CFU/ml L. fermentum (Figure 4a).
Untreated mock fermentations did not yield any reduction
in contamination.
Discussion
The goal of this study was to identify phage exolytic lysins
that can be used as antimicrobials toward Gram positive
LAB known to contaminate fuel ethanol fermentations.
Figure 4 λSa2 and LysA exolytic activity in mock fermentations of corn fiber hydrolysates inoculated with L. fermentum and L. reuteri.
a) Hydrolysate inoculated with 1x104 CFU/ml L. fermentum isolate BR0315–1 and treated with λSa2 endolysin at 250 ng/μl (red), 75 ng/μl (green),
25 ng/μl (purple) and LysA at 25 ng/μl (blue), PBS buffer control (black). b) Hydrolysate inoculated with 1x107 CFU/ml L. fermentum isolate BR0315-1 and
treated with 25 ng/μl (purple) λSa2 endolysin, PBS buffer control (black). c) Hydrolysate inoculated with 1x104 CFU/ml L. reuteri strain B-14171 and treated
with LysA at 760 ng/μl (orange), PBS buffer control (black). Data represent the average of four plate counts (n=4) ± SEM.
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phage lysins (LysA, Lysa2, LysgaY and λSa2 endolysin), that
show high activity against LAB contaminants from fuel
ethanol facilities. These enzymes have broad exolytic activ-
ity in vitro towards numerous Gram positive LAB includ-
ing several fermentation isolates of L. fermentum.
Although LysA, LysA2 and LysgaY, and λSa2 endolysin all
demonstrated exolytic activity against lactobacilli, the
lactobacilli lysin LysA and the streptococcal λSa2 phage
endolysin showed the greatest efficacies to reduce popula-
tions of L. fermentum. Interestingly, λSa2 endolysin also
exhibited the broadest lytic activity towards the LAB and
other Gram positive bacteria tested here.
It is virtually impossible to avoid LAB contaminations
in fuel ethanol fermentations, and therefore, the risk of
reduced ethanol yield is a major concern. The most
common commercially available products used to con-
trol contamination in fuel ethanol facilities are based on
the antibiotics virginiamycin and penicillin [2,9] with
recommended dosages ranging in fuel ethanol fermenta-
tions between 0.25–2.0 ppm [10] which makes the fuel
ethanol industry one of the largest consumers of antibio-
tics. However, the emergences of antibiotic resistant
lactobacilli have occurred in fuel ethanol production fa-
cilities [9,17]. Phage lysins can avoid many resistance pit-
falls associated with antibiotic use. Typically antibiotic
resistance is a consequence of a bacterial mutation or
acquisition of genes that improve the fitness of the re-
cipient bacterium allowing it to evade the action of anti-
biotics. These adaptations generally occur inside the
bacterial cell and employ three general strategies; modi-
fication of the drug, alteration of the target (or its level
of expression), or decreased accessibility of the drug to
its target (reviewed by Bischoff et al. [33]). Whereas,
phage lysins target the PG, which is located outside the
cytoplasmic membrane and reduce the number ofpossible known mechanisms by which bacterial resist-
ance typically emerges [34].
Lysins are currently being used as disinfectants in in-
dustrial settings. Lysozyme which is isolated from hen
egg albumen is also a PG hydrolytic enzyme similar to
phage encoded lysins. It has been found to be useful in
controlling unwanted bacteria in wines at concentrations
of 250–500 mg l−1 [35]. Although lysozyme has been
found to inhibit undesirable malolactic fermentation by
Oenococcos oeni, strains of pediococci and lactobacilli,
which are usually blamed for serious defects in musts
and wines, were resistant [36]. Bacteria are also known
to produce various PG hydrolases, for example, a Strep-
tomyces strain produces a mixture of muramidases and
proteases that are secreted into the medium. When col-
lected, this mixture has shown broad lytic activity
against a variety of wine-relevant LAB, however lytic ac-
tivity on L. fermentum was not tested [37] therefore it is
uncertain if this approach could be used in a fuel etha-
nol fermentation system. Other examples for the poten-
tial use of lysin-based environmental disinfectants
include lysins PlyC and Lysostaphin [38]. The strepto-
coccal lysin PlyC was found to be 1,000 fold more active
on a per weight basis than a commercially available oxi-
dizing disinfectant and was shown to retain effective-
ness when tested in the presence of non-ionic
detergents, hard water, and organic material [38]. The
staphylococcal lysin lysostaphin, a PG hydrolase bac-
teriocin, has been shown to be effective in killing
methicillin resistant S. aureus (MRSA) on solid sur-
faces [39]. Therefore the study of phage-encoded lytic
enzymes with activity against problematic LAB in fuel
ethanol fermentations is highly relevant and needed.
The differences we observed in exolytic activity of the
four lysins against different species Table 1, are possibly
reflected in compositional changes in the cell walls. Of
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only been experimentally determined for LysA2. LysA2
cleaves the bond established between the bridging aspar-
tic acid and the final D-alanine of one of the tetrapep-
tides involved in the binding of adjacent PG chains of
L. casei (Figure 1b) [28]. This particular architecture is
typical of lactobacilli as well as many other LAB, includ-
ing the pediococci [25]. However, some lactobacilli were
only moderately exolysed by LysA2 (L. fermentum, L.
reuteri, and L. gasseri) while others (L. delbrueckii, L.
malefermentans, L. paracasei) were not sensitive to the
lysin. A plausible explanation for this lysin specificity
could be derived from the cell wall binding domain. Cer-
tain Listeria monocytogenes lysins have cell wall binding
domains that specifically recognize and bind to teichoic
acids before degradation of the peptidoglycan can occur
[40]. For the lysins tested here, it is not known if and
how the cell wall binding domains are interacting with
the cell wall or the prevalence of potential cell wall bind-
ing epitopes on the cell surface of the LAB tested in
this study. Similarly, ethanol stresses on the cell wall
(Figure 3b) or phase of growth (logarithmic, stationary,
or biofilm) may contribute significantly to sensitivity to
lysins, although lysins are generally believed to be active
on all phases of cell growth.
Interestingly, the streptococcal enzyme, λSa2 prophage
endolysin, was our strongest candidate antimicrobial for
lactobacilli. The most likely explanation for this cross-
genera activity is that the λSa2 endolysin glycosidase lytic
domain targets the conserved sugar backbone common to
all PG. This C-terminal N-acetyl-glucosaminidase cleaves
the glycan component of the PG on the reducing side of
GlcNAc (Figure 1a) [30]. The N-terminal λSa2 endolysin
catalytic domain harbors a D-glutaminyl-L-lysine endopep-
tidase, which cleaves the peptide bonds between the two
amino acids D-glutamine and L-lysine [30]. This exact
sequence is present in most lactobacilli PG, but is lack-
ing in the PG of L. fermentum (Figure 1a), the species
where λSa2 endolysin is apparently most active (Table 1).
L. fermentum has an L-ornithine substituted for L-lysine
at the third position of the tetrapeptide (Figure 1a). Al-
though we have no biochemical data to indicate which
domain (glycosidase or endopeptidase) is responsible for
the lysis of the LAB strains, it is possible that the λSa2
endolysin endopeptidase domain functions to cleave this
bond in LABs, when considering the similarity between
ornithine and lysine (lysine harbors 4 carbons, rather
than 3 for ornithine in the amino terminal alkyl side
chains). In support of this possibility is the fact that
LysA2 endopeptidase activity [hydrolyzes the bond be-
tween the terminal D-alanine of the PG tetrapeptide and
the D-aspartic acid residue that forms the bridge with
the L-lysine of a neighboring PG chain] was reported
to function on species that harbor either an L-lysine oran L-ornithine at position three in the neighboring tetra-
peptide [28]. Although not a definitive or even a direct
comparison, this suggests a degree of flexibility in the rec-
ognition sequences surrounding the cut site of these PG
hydrolase lytic domains.
It is interesting to speculate on whether or not sensi-
tivity to ethanol will be a significant factor in the efficacy
of the lytic enzymes we have tested. Although, final fer-
mentation conditions yield ethanol concentrations that
may be greater than 5%, the starting feedstock is a major
culprit for introducing LAB contamination to the fer-
mentation system [4], a point at which the fermentation
is highly sensitive to contamination [41]. At this initial
aerobic stage in the fermentation there is no significant
ethanol concentration that would be ideal for lysin treat-
ment therefore ethanol levels might not be a factor. Cer-
tainly enzymes that have a broad range of activity
regardless of ethanol concentration might provide a
longer-lived protection during the fermentation process,
especially if they are designed to be secreted from re-
combinant fermentative yeast throughout the fermenta-
tion process. Yet to be determined is whether a broader
species-target range or biochemical resilience under
ethanolic fermentation conditions is more important
for the optimal antimicrobial when considering the
complex environment of a lignocellulosic fermentation.
The increased activity of LysA2 and LysgaY against L.
brevis with increasing ethanol concentration is intriguing
and suggests these might be preferred enzymes if treating
L. brevis contaminants in late fermentations.
From this study, LysA, LysA2, LysgaY and λSa2 endo-
lysin were shown to be excellent candidate antibacterial
agents. By homology screening of these lysins to other
known PG hydrolase lytic and cell wall binding domains
there is no shortage of phage lysins for future consider-
ation as public datasets contain numerous putative lytic
PG hydrolases from both bacterial (prophage) and phage
genome origins. Due to the high interest in phages that
impinge on yogurt production, there are hundreds of
known lactobacilli phage, with nine complete Lactobacil-
lus phage genomes and 11 Lactobacillus poly-lysogenic
bacterial genomes with sequence available on the NCBI
website [42]. For example, lactobacilli lysins from Φadh
[43], and Φg1e [44,45] have been shown to be functional
lytic enzymes, although their ability to exolyse cells has
not been reported. There is also a report of an amidase
domain from the PL-1 that infects L. casei [46] and a
muramidase (Mur-LH) that have shown a broad species
activity ([47]. However, due to limitations in the species
range of lytic activity each candidate will need to be
tested empirically against target LAB.
Our most broadly effective enzymes, λSa2 endolysin and
LysA, were tested in mock fermentations and shown to ef-
fectively reduce the LAB load by up to 2 orders of
Table 2 Lysins bioinformatically selected from GenBank
for cloning into pET21a protein expression vector
Lysin Origin Reference or
Source
ABJ8901 Lactobacillus brevis ATCC367 [GenBank:ABJ63875]
BAG8101 Lactobacillus fermentum IFO 3956 [GenBank:BAG27815]
Lyb5 Lactobacillus fermentum phage
ΦPBY5
[32]
LysA Lactobacillus fermentum Br11 [27]
LysA2 Lactobacillus casei phage ΦA2 [28]
LysgaY Lactobacillus fermentum phage
ΦgaY
[29]
λSa2 endolysin Streptococcus agalactiae [30]
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these initial trials do not necessarily reflect normal fermen-
tation conditions. In order to easily detect changes in target
contaminant profiles, the mock trial was performed under
pre-sterilization conditions, such that the only contaminant
was L. fermentum, a scenario not likely in industrial fer-
mentations. Also, neither the yeast nor the LAB were
adapted for growth on hydrolysate, rather, they were both
grown in rich broth and then added to the hydrolysate.
This assay was designed to test the enzymes for activity
under hydrolysate conditions, the results of which are en-
couraging, but activity on the contaminant might be
affected by the cell wall of the contaminant during hydrol-
ysate growth conditions. Thus, the usefulness of these
enzymes in large scale fermentations remains to be
determined.
Due to the absence of PG in yeast cell walls, none of
these lysins including λSa2 endolysin had any catalytic ac-
tivity towards S. cerevisiae when applied externally and
should not adversely affect the fermentation process. In
addition, the heat of distillation and the heat of drying the
distiller’s grains should denature the lysins, minimizing any
potential impact on gut microflora of animals fed the etha-
nol co-products. Therefore, lysins appear to share qualities
worth considering for future works to protect fuel ethanol
fermentations from LAB contaminants.Conclusions
Phage lytic enzymes are strong candidate antimicrobials
to control LAB contamination in fuel ethanol fermenta-
tions. Four phage endolysins of Gram positive origin
(LysA, LysA2, LysgaY and λSa2 endolysin) demonstrate
lysis of LAB at pH and ethanol concentrations similarly
achieved during fuel ethanol fermentations. Two of
these enzymes (λSa2 endolysin and LysA) reduce LAB
by at least one log in mock fermentations. These qual-
ities make phage lytic enzymes excellent candidate
antimicrobials for testing in biofuel fermentations aseither additives or engineered to be expressed by the fer-
mentative yeast.
Methods
Constructs, strains, and plasmids
The lysins that were bioinformatically selected and
synthesized or generously gifted to us for use in this
study are listed in Table 2. LysA, LysA2, LysgaY genes
were bioinformatically reverse translated with an E. coli
codon bias and gene nucleotide sequences were com-
mercially synthesized and cloned into pUC57 vector
(GenScript, Piscataway, NJ). The Streptococcus agalac-
tiae phage λSa2 endolysin (EMD Biosciences, San Diego,
CA) was obtained as a gift from D. Pritchard [30]. LysA,
LysA2, LysgaY and λSa2 endolysin genes were sub-
cloned into the pET21a E. coli expression vector (EMD
Biosciences, San Diego, CA) and maintained in E. coli
DH5α (Invitrogen, Carlsbad, CA) at 37°C in LB medium
supplemented with 150 μg/ml ampicillin for plasmid puri-
fication, maintenance and DNA sequence verification.
The bacterial strains used and their origin are listed in
Table 1. Staphylococci and streptococci were grown in
Tryptic Soy Broth (TSB; Difco Laboratories) medium
with shaking at 37°C, E. coli was grown in Luria-Bertani
(LB; Difco Laboratories) medium broth at 37°C with
shaking, and lactobacilli were grown in de Man, Rogosa
and Sharp (MRS; Difco Laboratories) medium at 37°C
without shaking. S. cerevisiae was grown overnight in
yeast extract peptone (YP; Becton, Dickinson, and Co.
Sparks, MD) medium supplemented with 4% (w/v) glu-
cose at 30°C with shaking.
Expression and purification of lysins
All lysin proteins were over expressed in E. coli and puri-
fied via nickel column chromatography as previously
described [48]. Purified pET21a harboring the lysin genes
of interest, were transformed into E. coli BL21 (DE3)
(Invitrogen, Carlsbad, CA) by heat stock at 42°C for 30 s.
BL21 (DE3) transformants were cultured at 37°C in 1 L
modified LB (mLB) medium (15 g/l tryptone, 8 g/l yeast
extract, 5 g/l NaCl) supplemented with 150 μg/ml ampi-
cillin. Mid log phase (OD600 nm of 0.4–0.6) cultures were
induced with 1 mM IPTG (isopropyl-beta-D-thiogalacto-
pyranoside), followed by 10°C overnight incubation.
Induced cells were pelleted, resuspended in 10 ml of lysis
buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imid-
azole, 30% glycerol, pH 8.0), and sonicated on ice for
15 min (1 s pulses separated by 1 s rests). After cen-
trifugation (9000 x g for 30 min), proteins were puri-
fied from the cleared supernatant by immobilized
metal ion affinity chromatography, using nickel-NTA
Superflow resin (QIAGEN, Valencia, CA). Resin was
washed with 40 column volumes (CV) of lysis buffer,
and 15 CV of wash buffer (50 mM NaH2PO4, 300 mM
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proteins were eluted with elution buffer (50 mM
NaH2PO4, 300 mM NaCl, 250 mM imidazole, 30% gly-
cerol, pH 8.0) to achieve >90% purity. Protein elutes were
filter sterilized (0.22 μm), concentration measured spectro-
photometrically using a NanoDrop ND-1000 (NanoDrop
Technologies, Wilmington, DE), and purities were deter-
mined via sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE).
Zymogram and turbidity reduction assays
The purified proteins and Kaleidoscope protein stan-
dards (Bio-Rad) were analyzed using 15% SDS-PAGE,
with or without 300 ml equivalent of mid log phase
(OD600 nm = 0.4–0.6) lactobacilli cells that were pelleted,
and washed twice in buffer (50 mM NaH2PO4, 150 mM
NaCl, pH 8.0) prior to addition to the pre-polymerized
gel. Gels were electrophoresed at 150 volts (~1 h). SDS-
PAGE gels were Coomassie stained and zymograms were
washed in excess H2O for 1 h and incubated at 24°C in
50 mM Tris–HCl, 1% Triton X114, pH 5.5, until visible
translucent bands appeared and images taken (~18 h).
The turbidity assays were performed in a Molecular
Devices Spectra Max 340 plate reader. Strains were
grown to mid-log phase (OD600 nm = 0.4 – 0.6) at 37°C,
washed in buffer (20mM phosphate, 150mM NaCl, 30%
glycerol: pH 8.0), pelleted, and frozen at −80°C. Cells
were thawed on ice and resuspended to OD600 nm = 2.0
in buffer (20mM phosphate, 150mM NaCl: pH 5.5, un-
less otherwise stated). Lysins were standardized to 1 μM
per well and the assay started by the addition of 100 μl
of cell suspension, giving an initial OD600nm=1. Immedi-
ately, absorbance (OD600nm) readings were taken every
30 s for 30 min and specific activities were determined
on a sliding scale as described by Becker et al. [49] as
OD600nm/min/μM. Control samples with cells alone (no
enzyme) were included, and ‘cells alone’ specific activities
were subtracted from experimental sample specific activ-
ities control for the effect of autolysis.
Preparation of mock fermentation
Corn fiber, obtained from a commercial wet-mill ethanol
facility, was hydrolyzed by dilute acid treatment as previ-
ously described [50]. Briefly, sulfuric acid (1% w/v) was
added to a suspension of corn fiber (10% w/v) and heated
to 121°C for 1 h, then neutralized to pH 5.5 with NaOH.
The hydrolysate was cleared of particulate matter by cen-
trifugation. Sterility was confirmed by plating aliquots of
hydrolysate on MRS agar. The S. cerevisiae strain NRRL
Y-2034 was grown overnight in YP broth supplemented
with 4% (w/v) glucose at 32°C with shaking at 200 rpm.
Cells were harvested by centrifugation and resuspended
in a volume of phosphate buffered saline (PBS; Fisher
Scientific) pH7.4, necessary to obtain an OD600nmequivalent of 80. L. fermentum strain BR0315-1 and L.
reuteri strain B-14171 were grown to mid log phase
(OD600nm = 0.4-0.6) (as described above), diluted appro-
priately in PBS to a density of 1x105 CFU/ml or 1x108
CFU/ml (OD600nm =1.0 is ~4.5x10
8 CFU/ml) and used as
inoculums for mock fermentation analysis.
Mock fermentation cultures were prepared by combining
10 ml of corn fiber hydrolysate, 100 μl 12% (NH4)2SO4,
150 μl cellulase (Celluclast; Novozymes, Bagsvaerd, Den-
mark), 150 μl Cellobiase (Novozyme 188; Novozymes), and
125 μl S. cerevisiae (OD600nm equivalent of 80), in a 50 ml
conical tube. For each lysin treatment analysis, 800 μl of
mock fermentation prep was spiked with 100 μl mid log
phase LAB cells (1x105 CFU/ml or 1x108 CFU/ml), and
treated with 100 μl purified His6-tagged lysin. ‘No-lysin’
controls were included. Mock fermentations were cultured
at 30°C with aliquots taken at 0 min, 30 min, and 60 min
intervals. The aliquots were titered by plating on 1.5%
MRS agar containing 100 μg/ml cyclohexamide (to inhibit
growth of S. cerevisiae) and incubated anaerobically using
the AnaeroPack System (Mitsubishi, Tokyo, Japan) at 37°C
for 24 h.
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